FPF
ETRM

FNY Partners Fund’s EnteroMedics Inc. ETRM Stock Holding History

FNY Partners Fund’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,000
Closed -$40K – 1576
2017
Q1 		$40K Buy
+7,000
New +$51.8K ﹤0.01% 785

Other funds holding ETRM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

FNY Partners Fund's ETRM Position: Q2 2017 in Review

FNY Partners Fund sold out of EnteroMedics Inc. (ETRM) in Q2 2017, closing a stake of 7,000 shares — an estimated $40K sold.

FNY Partners Fund first reported a position in ETRM in Q1 2017 and held it in 1 quarter. The position peaked at $40K in Q1 2017. 16 funds tracked by Wall St. Rank hold ETRM as of Q2 2017.

  • FNY Partners Fund reported no remaining EnteroMedics Inc. position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 7,000 EnteroMedics Inc. shares in Q2 2017, an estimated $40K.
  • FNY Partners Fund first reported a position in EnteroMedics Inc. in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's EnteroMedics Inc. position peaked at $40K in Q1 2017.
  • 16 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.